Can chronic hyperinsulinemia impair brain insulin signaling and reduce amyloid beta clearance?

Chronic hyperinsulinemia is biologically linked to pathways relevant to neurodegeneration, but the full claim is best regarded as mechanistically credible rather than demonstrated in humans.

Clinical and translational evidence

• In healthy older adults undergoing hyperinsulinemic-euglycemic clamp testing, lower peripheral insulin sensitivity was associated with weaker insulin-related, working-memory BOLD responses, consistent with reduced cerebral insulin responsiveness.
• Randomized clamp studies in older adults found that acute peripheral insulin infusion increased cerebrospinal-fluid (CSF) amyloid-beta (Aβ) concentrations. These results show an acute insulin-related perturbation of CSF Aβ, but CSF concentration alone does not distinguish altered Aβ production from reduced clearance or establish a chronic effect.

Mechanistic basis

• Insulin receptors in the brain recruit IRS proteins and activate PI3K–AKT signaling, supporting neuronal metabolism, survival, and synaptic plasticity. Prolonged hyperinsulinemia may reduce insulin transport into the brain and may be associated with impaired downstream insulin responsiveness.
• IDE directly degrades Aβ. In vitro and human-neuron lysate experiments show that insulin inhibits IDE-mediated Aβ degradation. The reported apparent Km was approximately 85 nM for insulin versus approximately 25 μM for Aβ, indicating substantially greater apparent IDE affinity for insulin; inhibition approached near-complete levels at the highest insulin concentrations tested.

Interpretation

• These findings establish IDE as a credible molecular site of insulin–Aβ competition and make reduced IDE-mediated Aβ degradation a plausible consequence of sustained high insulin exposure.
• However, existing human data do not show that chronic peripheral hyperinsulinemia produces sustained insulin concentrations in relevant brain compartments sufficient to occupy IDE, nor do they directly measure chronic brain Aβ clearance kinetics.

Bottom line

• Chronic hyperinsulinemia plausibly impairs brain insulin signaling and could reduce one route of Aβ clearance through IDE competition, but direct human proof of chronic, IDE-mediated impairment of cerebral Aβ clearance is not yet established.